Home › Funds › Grantham, Mayo, Van Otterloo & Co. LLC › DGX
Grantham, Mayo, Van Otterloo & Co. LLC position in DGX
QUEST DIAGNOSTICS INC · Health Care
Grantham, Mayo, Van Otterloo & Co. LLC reported holding 1,930,280 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$449.9M, representing 0.97% of its reported portfolio and ranking #32 among its reported holdings. Grantham, Mayo, Van Otterloo & Co. LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Grantham, Mayo, Van Otterloo & Co. LLC's DGX position evolved
Grantham, Mayo, Van Otterloo & Co. LLC first disclosed a stake in DGX in Q3 2023 at 1,636,407 shares (US$199.4M). The position peaked in Q3 2026 at 1,930,280 shares, worth US$449.9M. Across 13 filings, Grantham, Mayo, Van Otterloo & Co. LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,930,280 shares valued at US$449.9M — an increase of 42,073 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.64M | $199.41M | New |
| Q4 2023 | 1.71M | $235.11M | Add |
| Q1 2024 | 2.04M | $271.98M | Add |
| Q2 2024 | 2.13M | $291.38M | Add |
| Q3 2024 | 2.24M | $348.19M | Add |
| Q4 2024 | 2.27M | $342.30M | Add |
| Q1 2025 | 2.01M | $339.51M | Reduce |
| Q2 2025 | 1.75M | $313.98M | Reduce |
| Q3 2025 | 1.75M | $332.83M | Hold |
| Q4 2025 | 1.82M | $315.14M | Add |
| Q1 2026 | 1.88M | $369.04M | Add |
| Q2 2026 | 1.89M | $400.21M | Hold |
| Q3 2026 | 1.93M | $449.89M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 25 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), DAVIS SELECTED ADVISERS (US$309.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.64M sh · $1.08B · Q3 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- DAVIS SELECTED ADVISERS 1.33M sh · $308.97M · Q3 2026
- M&G Plc 770.10K sh · $179.43M · Q3 2026
More on Grantham, Mayo, Van Otterloo & Co. LLC
FAQ
How long has Grantham, Mayo, Van Otterloo & Co. LLC held DGX?
Grantham, Mayo, Van Otterloo & Co. LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Grantham, Mayo, Van Otterloo & Co. LLC's current position in DGX?
As of Q3 2026, Grantham, Mayo, Van Otterloo & Co. LLC holds 1.93M shares of DGX (QUEST DIAGNOSTICS INC), valued at $449.89M, representing 0.97% of its reported portfolio and ranking #32.
Has Grantham, Mayo, Van Otterloo & Co. LLC been buying or selling DGX?
In the latest 13F filing (Q3 2026), Grantham, Mayo, Van Otterloo & Co. LLC increased its position in DGX. The position peaked in Q3 2026 at 1.93M shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., DAVIS SELECTED ADVISERS, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.